|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - BridgeBio Pharma Inc.
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-07-03 Purchase |
2019-07-08 9:26 pm |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma Inc. 10% Owner |
882,353 | $29.9 | $26,382,795 | 24,575,500 (Indirect) |
View |
| 2019-07-01 Purchase |
2019-07-03 4:30 pm |
BridgeBio Pharma Inc. | BBIO | KKR Genetic Disorder L.P. ROBERTS GEORGE R KRAVIS HENRY R KKR Management LLC KKR & Co. Inc. KKR Group Holdings Corp. KKR Management Holdings Corp KKR Management Holdings L.P. KKR Genetic Disorder GP LLC 10% Owner |
2,647,100 | $17 | $45,000,700 | 36,900,660 (Indirect) |
View |
| 2019-07-01 Purchase |
2019-07-03 4:17 pm |
BridgeBio Pharma Inc. | BBIO | Sinha Uma Chief Scientific Officer |
14,000 | $17 | $238,000 | 14,000 (Direct) |
View |
| 2019-07-01 Purchase |
2019-07-03 4:14 pm |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS See Remarks |
7,000 | $17 | $119,000 | 180,767 (Direct) |
View |
| 2019-07-01 Purchase |
2019-07-03 4:12 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remark |
55,500 | $17 | $943,500 | 368,446 (Direct) |
View |
| 2019-06-27 Purchase |
2019-06-28 7:02 pm |
BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL PERFORMANCE LLC Viking Global Equities Master Ltd. Viking Long Fund GP LLC Viking Long Fund Master Ltd. HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
4,705,900 | $17 | $80,000,300 | 26,620,992 (Indirect) |
View |
| 2019-06-27 Purchase |
2019-06-28 7:02 pm |
BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
4,705,900 | $17 | $80,000,300 | 26,620,992 (Indirect) |
View |
| 2019-05-24 Purchase |
2019-05-29 7:13 pm |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma Inc. 10% Owner |
1,103,848 | $25.93 | $28,622,779 | 23,693,148 (Direct) |
View |
| 2018-12-10 Purchase(A) |
2018-12-13 6:14 pm |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma LLC 10% Owner |
40,653 | $13.33 | $542,063 | 22,589,300 (Direct) |
View |
| 2018-12-06 Purchase(A) |
2018-12-13 6:13 pm |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma LLC 10% Owner |
80,144 | $13.67 | $1,095,867 | 22,548,648 (Direct) |
View |
| 2018-12-10 Sale |
2018-12-12 5:44 pm |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma LLC 10% Owner |
40,653 | $13.33 | $542,063 | 22,589,300 (Direct) |
View |
| 2018-12-06 Sale |
2018-12-10 7:25 pm |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma LLC 10% Owner |
80,144 | $13.67 | $1,095,867 | 22,548,648 (Direct) |
View |
| 2018-12-03 Purchase |
2018-12-06 8:48 pm |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma LLC 10% Owner |
2,853,848 | $14.92 | $42,589,911 | 22,468,504 (Direct) |
View |
| 2018-06-22 Purchase |
2018-06-26 4:30 pm |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma LLC 10% Owner |
1,000,000 | $17 | $17,000,000 | 19,614,656 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-07-01 Conversion |
2019-07-03 4:30 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | KKR Genetic Disorder L.P. ROBERTS GEORGE R KRAVIS HENRY R KKR Management LLC KKR & Co. Inc. KKR Group Holdings Corp. KKR Management Holdings Corp KKR Management Holdings L.P. KKR Genetic Disorder GP LLC 10% Owner |
34,253,560 | $0 | 36,900,660 (Indirect) |
View |
| 2019-07-01 Conversion |
2019-07-03 4:30 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | KKR Genetic Disorder L.P. ROBERTS GEORGE R KRAVIS HENRY R KKR Management LLC KKR & Co. Inc. KKR Group Holdings Corp. KKR Management Holdings Corp KKR Management Holdings L.P. KKR Genetic Disorder GP LLC 10% Owner |
81,022,728 | $0 | 36,900,660 (Indirect) |
View |
| 2019-07-01 Conversion |
2019-07-03 4:30 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | KKR Genetic Disorder L.P. ROBERTS GEORGE R KRAVIS HENRY R KKR Management LLC KKR & Co. Inc. KKR Group Holdings Corp. KKR Management Holdings Corp KKR Management Holdings L.P. KKR Genetic Disorder GP LLC 10% Owner |
36,246,892 | $0 | 36,900,660 (Indirect) |
View |
| 2019-07-01 Conversion |
2019-07-03 4:30 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | KKR Genetic Disorder L.P. ROBERTS GEORGE R KRAVIS HENRY R KKR Management LLC KKR & Co. Inc. KKR Group Holdings Corp. KKR Management Holdings Corp KKR Management Holdings L.P. KKR Genetic Disorder GP LLC 10% Owner |
50,446,452 | $0 | 36,900,660 (Indirect) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:17 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director |
6,886 | $0 | 163,427 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:17 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director |
19,318 | $0 | 163,427 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:17 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director |
59,381 | $0 | 163,427 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:17 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director |
42,100 | $0 | 163,427 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:17 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director |
35,742 | $0 | 163,427 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:17 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director |
6,886 | $0 | 163,427 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:17 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director |
19,318 | $0 | 163,427 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:17 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director |
59,381 | $0 | 163,427 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:17 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director |
42,100 | $0 | 163,427 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:17 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director |
35,742 | $0 | 163,427 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK COO, Chairman |
47,165 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK COO, Chairman |
132,317 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK COO, Chairman |
66,729 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK COO, Chairman |
406,723 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK COO, Chairman |
418,016 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK COO, Chairman |
290,476 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK COO, Chairman |
47,165 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK COO, Chairman |
132,317 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK COO, Chairman |
66,729 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK COO, Chairman |
406,723 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK COO, Chairman |
418,016 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK COO, Chairman |
290,476 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS See Remarks |
8,420 | $0 | 180,767 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS See Remarks |
8,420 | $0 | 180,767 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS See Remarks |
151,563 | $0 | 180,767 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS See Remarks |
5,364 | $0 | 180,767 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS See Remarks |
8,420 | $0 | 180,767 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS See Remarks |
8,420 | $0 | 180,767 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS See Remarks |
151,563 | $0 | 180,767 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS See Remarks |
5,364 | $0 | 180,767 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remark |
294,706 | $0 | 368,446 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remark |
18,240 | $0 | 368,446 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remark |
294,706 | $0 | 368,446 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remark |
18,240 | $0 | 368,446 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Chairman |
47,165 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Chairman |
132,317 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Chairman |
66,729 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Chairman |
406,723 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Chairman |
418,016 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Chairman |
290,476 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Chairman |
47,165 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Chairman |
132,317 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Chairman |
66,729 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Chairman |
406,723 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Chairman |
418,016 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Chairman |
290,476 | $0 | 1,361,426 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Director |
323,270 | $0 | 7,624,367 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Director |
906,905 | $0 | 7,624,367 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Director |
1,742,631 | $0 | 7,624,367 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Director |
2,744,459 | $0 | 7,624,367 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Director |
1,907,102 | $0 | 7,624,367 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Director |
400,375 | $0 | 7,624,367 (Indirect) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Director |
927,686 | $0 | 7,624,367 (Indirect) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Director |
323,270 | $0 | 7,624,367 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Director |
906,905 | $0 | 7,624,367 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Director |
400,375 | $0 | 7,624,367 (Indirect) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Director |
1,742,631 | $0 | 7,624,367 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Director |
927,686 | $0 | 7,624,367 (Indirect) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Director |
2,744,459 | $0 | 7,624,367 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Director |
1,907,102 | $0 | 7,624,367 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
3,368 | $0 | 12,630 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
9,262 | $0 | 12,630 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
3,368 | $0 | 12,630 (Direct) |
View |
| 2019-07-01 Exercise |
2019-07-03 4:12 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
9,262 | $0 | 12,630 (Direct) |
View |
| 2019-06-27 Conversion |
2019-06-28 7:02 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL PERFORMANCE LLC Viking Global Equities Master Ltd. Viking Long Fund GP LLC Viking Long Fund Master Ltd. HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
11,736,137 | $0 | 26,620,992 (Indirect) |
View |
| 2019-06-27 Conversion |
2019-06-28 7:02 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL PERFORMANCE LLC Viking Global Equities Master Ltd. Viking Long Fund GP LLC Viking Long Fund Master Ltd. HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
10,178,954 | $0 | 26,620,992 (Indirect) |
View |
| 2019-06-27 Conversion |
2019-06-28 7:02 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL PERFORMANCE LLC Viking Global Equities Master Ltd. Viking Long Fund GP LLC Viking Long Fund Master Ltd. HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
51,781,276 | $0 | 26,620,992 (Indirect) |
View |
| 2019-06-27 Conversion |
2019-06-28 7:02 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL PERFORMANCE LLC Viking Global Equities Master Ltd. Viking Long Fund GP LLC Viking Long Fund Master Ltd. HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
50,446,452 | $0 | 26,620,992 (Indirect) |
View |
| 2019-06-27 Conversion |
2019-06-28 7:02 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
11,736,137 | $0 | 26,620,992 (Indirect) |
View |
| 2019-06-27 Conversion |
2019-06-28 7:02 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
10,178,954 | $0 | 26,620,992 (Indirect) |
View |
| 2019-06-27 Conversion |
2019-06-28 7:02 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
51,781,276 | $0 | 26,620,992 (Indirect) |
View |
| 2019-06-27 Conversion |
2019-06-28 7:02 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
50,446,452 | $0 | 26,620,992 (Indirect) |
View |
| 2018-06-22 Conversion |
2018-06-26 4:30 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma LLC 10% Owner |
18,826,416 | $0 | 19,614,656 (Direct) |
View |
| 2018-06-22 Tax Withholding |
2018-06-26 4:30 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma LLC 10% Owner |
211,762 | $17 | 19,614,656 (Direct) |
View |
| 2018-06-22 Exercise |
2018-06-26 4:30 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma LLC 10% Owner |
332,262 | $10.83 | 19,614,656 (Direct) |
View |
| 2018-06-22 Exercise |
2018-06-26 4:30 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma LLC 10% Owner |
332,262 | $0 | 19,614,656 (Direct) |
View |
| 2018-06-22 Conversion |
2018-06-26 4:30 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma LLC 10% Owner |
2,909,029 | $0 | 19,614,656 (Direct) |
View |
| 2018-06-22 Conversion |
2018-06-26 4:30 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma LLC 10% Owner |
12,832,123 | $0 | 19,614,656 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Mon, 14 Oct 2019 10:35:50 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |